Oncology Institute Inc reports results for the quarter ended in June - Earnings Summary

Oncology Institute

09/08/2023 24:15

* Oncology Institute Inc  TOI.OQ  reported a quarterly
adjusted
loss of 19 cents​​ per share for the quarter ended in June. The
lone analyst forecast for the quarter was for a loss of 17 cents
per share.
    * Revenue was $80.22 million​; analysts expected $73.79
million. 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Oncology Institute Inc shares had risen by 76.3% this
quarter and lost 41.2% so far this year.
    * The company reported a quarterly loss of $16.9 million.
    * Wall Street's median 12-month price target for Oncology
Institute Inc is $4.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 11:15 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.17          -0.19          Missed
 Dec. 31 2022      -0.18          -0.25          Missed
 Sep. 30 2022      -0.18          -0.25          Missed